Research Training in Pulmonary Immunology and Allergy at MGH
MGH 肺部免疫学和过敏研究培训
基本信息
- 批准号:10202695
- 负责人:
- 金额:$ 67.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Research Training in Pulmonary Immunology and Allergy at MGH is a T32 renewal application that brings
together research programs of the Massachusetts General Hospital (MGH) Division of Pulmonary and Critical
Care Medicine (DPCCM), Allergy and Clinical Immunology Unit (ACIU), and Center for Immunology and
Inflammatory Diseases (CIID). This Training Program was created principally to provide comprehensive
training for physician-scientists in the DPCCM and ACIU fellowship programs interested in lung immunology
and allergic inflammation. The Program is designed to prepare the next generations of physician-scientists and
PhD-scientists to be leaders in lung immunology and allergy related research. In the first 3.5 years, this
Program has been highly successful with no unfilled slots and 100% academic retention. In addition, all of the
graduates of the Program have published at least one first-author publication and 73% have secured
independent funding. In this renewal application we capitalize on this success and momentum and provide
training in 10 scientific disciplines: (i) Adaptive Lung Immunity; (ii) Innate Lung Immunity; (iii) Allergic
Sensitization, Tolerance & Immunodeficiency; (iv) Lung Injury, Repair & Regeneration; (v) Molecular
Epidemiology & Genetics of Lung Disease and Allergy; (vi) Health Care Delivery Science in Pulmonary and
Allergy; (vii) Translational & Precision Medicine; (viii) Systems Biology, Single Cell Genomics & Epigenetics;
(ix) Microbiome; (x) Novel Imaging Modalities. The Program will have basic, translational, health outcomes and
epidemiology components. Specifically we seek to provide: 1) opportunities for mentored research in
disciplines that have the potential for high-impact discoveries; 2) outstanding research training through
didactics, seminars, and comprehensive mentoring; and 3) an environment and infrastructure that fosters
scholarly activity and career development into independent scientists. This application requests 10 training
positions that will be allocated to trainees who are committed to 2 to 3 years of research training. Eight MD or
MD/PhD candidates will be drawn from the highly competitive DPCCM and ACIU fellowship programs. Two
PhD trainees will be chosen from postdoctoral fellows in the laboratories of our mentors who are performing at
a high level and who have demonstrated a commitment to careers in pulmonary or allergy research. Two new
slots for PhD trainees are being requested based on trainee and mentor feedback indicating that our Program
would be strengthened, and the mission of the NIH better served, by having MDs and PhDs train side-by-side.
The 28 mentors in this Program were carefully chosen based on their track record of publications, grants,
mentoring, collaboration and interest in lung immunology and allergy. MGH provides an outstanding training
environment with over 1400 investigators, numerous training grants, research centers, trainee support groups,
and over $850 million in research grant awards. Furthermore, opportunities at Harvard Medical School, the
Harvard School of Public Health, and the Broad Institute provide additional valuable resources for trainees.
MGH的肺免疫学和过敏研究培训是T32更新申请,带来了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David C Christiani其他文献
Blood Pressure at Age 3-24 years in a Rural Community in China ♦ 700
中国农村社区 3-24 岁人群血压状况♦700
- DOI:
10.1203/00006450-199804001-00721 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Xiaobin Wang;Binyan Wang;Fangzhen Zhang;Changzhong Chen;Jianhua Yang;Zhian Fang;Xiaobin Zhang;David C Christiani;Scott T Weiss;Barry Zuckerman;Xiping Xu - 通讯作者:
Xiping Xu
David C Christiani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David C Christiani', 18)}}的其他基金
Harvard TH Chan Education and Research Center for Occupational Safety and Health
哈佛陈曾熙职业安全与健康教育研究中心
- 批准号:
10762715 - 财政年份:2023
- 资助金额:
$ 67.84万 - 项目类别:
OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42)
职业安全健康教育研究中心(T42)
- 批准号:
10456000 - 财政年份:2018
- 资助金额:
$ 67.84万 - 项目类别:
Multi-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy Controls
肺癌患者和健康对照组的多途径 DNA 修复能力测量
- 批准号:
10447766 - 财政年份:2018
- 资助金额:
$ 67.84万 - 项目类别:
OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42)
职业安全健康教育研究中心(T42)
- 批准号:
10249049 - 财政年份:2018
- 资助金额:
$ 67.84万 - 项目类别:
OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42)
职业安全健康教育研究中心(T42)
- 批准号:
9794128 - 财政年份:2018
- 资助金额:
$ 67.84万 - 项目类别:
Multi-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy Controls
肺癌患者和健康对照组的多途径 DNA 修复能力测量
- 批准号:
10228767 - 财政年份:2018
- 资助金额:
$ 67.84万 - 项目类别:
相似国自然基金
Cellular & Molecular Immunology
- 批准号:30824806
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:专项基金项目
相似海外基金
Development of lung and lung-liver microphysiological systems for studying SARS-CoV2 infection and immunology
开发用于研究 SARS-CoV2 感染和免疫学的肺和肺-肝微生理系统
- 批准号:
85104 - 财政年份:2021
- 资助金额:
$ 67.84万 - 项目类别:
Collaborative R&D
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
开发与翻译相关的肺腺癌基因工程小鼠模型,用于癌症免疫学研究
- 批准号:
9973758 - 财政年份:2020
- 资助金额:
$ 67.84万 - 项目类别:
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
开发与翻译相关的肺腺癌基因工程小鼠模型,用于癌症免疫学研究
- 批准号:
10608078 - 财政年份:2020
- 资助金额:
$ 67.84万 - 项目类别:
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
开发与翻译相关的肺腺癌基因工程小鼠模型,用于癌症免疫学研究
- 批准号:
10377568 - 财政年份:2020
- 资助金额:
$ 67.84万 - 项目类别:
Immunology and regenerative medicine-based approach to acute lung injury
基于免疫学和再生医学的急性肺损伤方法
- 批准号:
23592681 - 财政年份:2011
- 资助金额:
$ 67.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of ORMDL genes and genetic variants in lung immunology and asthma development (B16#)
ORMDL 基因和遗传变异在肺免疫学和哮喘发展中的作用 (B16
- 批准号:
162063319 - 财政年份:2009
- 资助金额:
$ 67.84万 - 项目类别:
Collaborative Research Centres
ALVEOLO-CAPILLARY SIGNALING IN LUNG IMMUNOLOGY
肺免疫学中的肺泡毛细血管信号转导
- 批准号:
7034610 - 财政年份:2001
- 资助金额:
$ 67.84万 - 项目类别:
ALVEOLO-CAPILLARY SIGNALING IN LUNG IMMUNOLOGY
肺免疫学中的肺泡毛细血管信号转导
- 批准号:
7265112 - 财政年份:2001
- 资助金额:
$ 67.84万 - 项目类别:
ALVEOLO-CAPILLARY SIGNALING IN LUNG IMMUNOLOGY
肺免疫学中的肺泡毛细血管信号转导
- 批准号:
6927447 - 财政年份:2001
- 资助金额:
$ 67.84万 - 项目类别:
ALVEOLO-CAPILLARY SIGNALING IN LUNG IMMUNOLOGY
肺免疫学中的肺泡毛细血管信号转导
- 批准号:
7643372 - 财政年份:2001
- 资助金额:
$ 67.84万 - 项目类别:














{{item.name}}会员




